SEC Form 8-K Summary
Registrant: 8i Acquisition 2 Corp. (proposed business combination with EUDA Health Limited, associated with EUDA Health Holdings Ltd.)
Reporting period and filing date: The report covers events beginning November 8, 2022 and was signed November 10, 2022. It reports actions related to the proposed business combination and Nasdaq listing requirements.
Business Context and Material Transactions
- 8i, EUDA and an institutional investor entered into a Prepaid Forward Agreement dated November 9, 2022.
- The transaction permits the investor, but does not require it, to purchase or reverse redemptions of up to 1,400,000 8i ordinary shares. These shares are intended to support the minimum unrestricted public share market value required for Nasdaq listing and increase the likelihood of closing the business combination.
- The investor will receive a prepayment from 8i’s trust account based on the number of shares involved and the applicable redemption price. The filing also provides for payment based on 100,000 additional shares purchased before closing.
- 8i and Greentree Financial Group terminated their November 1, 2022 Forward Purchase Agreement on November 9, 2022.
Financial Metrics, Liquidity and Capitalization
- Redemptions: 8,195,770 shares were tendered for redemption in connection with the business combination.
- Expected redemption price: Approximately $10.08 per share.
- The filing does not provide revenue, profit, operating cash flow, margins, debt balances, or a complete post-redemption trust-account balance.
- The Prepaid Forward Agreement uses trust-account funds and could result in future cash or share obligations for the combined company.
- At maturity, the counterparty may be entitled to consideration equal to $2.50 multiplied by the number of recycled shares less terminated shares, in addition to specified cash or share settlement amounts.
Material Changes Versus Prior Disclosure
- The previously disclosed Greentree forward purchase arrangement was terminated and replaced with the Prepaid Forward Agreement.
- The proxy statement was supplemented to reflect the new arrangement, the high level of redemptions, updated business-combination ownership assumptions, and related transaction risks.
- Post-business-combination ownership disclosures indicate that Watermark Developments Limited is expected to receive 9,660,000 shares, representing approximately 30.8% assuming no redemptions and approximately 40.5% assuming maximum redemptions.
- 8i’s directors and executive officers as a group are projected to own approximately 17.2% assuming no redemptions and 22.7% assuming maximum redemptions. These are transaction projections, not completed ownership results.
Guidance, Outlook, Risks and Unusual Items
- The Prepaid Forward Agreement’s initial reset price is $10.00 per share and may be reduced based on trading prices or certain issuances of securities at a lower effective price, subject to a stated $5.00 floor for one component of the formula.
- Maturity occurs on the earlier of the first anniversary of closing or a date selected by the investor following a VWAP trigger involving trading below $3.00 per share.
- Settlement may be in cash or shares. If share settlement would equal at least 20% of the combined company’s outstanding shares and shareholder approval is required but not obtained, the applicable portion must be paid in cash.
- If 8i or EUDA terminates the Prepaid Forward Agreement or specified additional termination events occur, they may owe a break-up fee consisting of the investor’s uncapped reasonable transaction expenses plus $1 million.
- The filing identifies risks including failure to complete the business combination, insufficient cash after redemptions, failure to maintain Nasdaq listing, regulatory or shareholder-approval delays, limited operating history and net losses at EUDA Health, execution and growth risks, market acceptance, litigation, intellectual-property issues, and general market conditions.
- No operating guidance or quantified financial outlook for EUDA Health is provided in this filing.
Key Facts Investors Should Verify
- Whether the business combination closed and the actual number of shares ultimately purchased or recycled under the Prepaid Forward Agreement.
- The final redemption price, trust-account balance, available cash, and compliance with Nasdaq’s minimum public-float market-value requirement.
- The final capitalization and ownership percentages after redemptions, transaction issuance, warrants, rights, and any future share settlement.
- Potential cash or dilution exposure from the reset-price provisions, maturity consideration, excess-share provisions, and the break-up fee.
- EUDA Health’s historical financial statements, operating losses, cash needs, debt, and ability to fund its business plan, which are not detailed in this 8-K.